Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/23/2012WO2012018791A3 Preparation of prasugrel hydrochloride
08/23/2012WO2012013418A3 Skin care compositions comprising substituted monoamines
08/23/2012WO2012012541A3 SUSTAINED RELEASE siRNA FOR OCULAR DRUG DELIVERY
08/23/2012WO2011163483A3 Polymers for biomaterials and therapeutics
08/23/2012WO2011161465A3 Composition for treatment of skin
08/23/2012WO2011151461A9 Autotaxin pathway modulation and uses thereof
08/23/2012WO2011080568A8 Novel pyrimidine compounds as mtor and pi3k inhibitors
08/23/2012WO2010116342A8 Non-steroidal compounds for androgen receptor modulation, processes for the preparation and uses thereof
08/23/2012US20120215185 Transdermal delivery system for the administration of rotigotine
08/23/2012US20120214967 Cross-linked glycopeptide-cephalosporin antibiotics
08/23/2012US20120214877 Stable rasagiline composition
08/23/2012US20120214876 Seizure and Migraine Treatments using the Bone Homeostasis Drug Cinacalcet
08/23/2012US20120214875 Phenoxybenzamine assay
08/23/2012US20120214874 Pharmaceutical formulations and methods of use
08/23/2012US20120214873 Cysteine for physiological injection
08/23/2012US20120214872 Bile acid or bile salt fatty acid conjugates
08/23/2012US20120214871 Leave-on nonsolid oil-continuous skin conditioning compositions containing 12-hydroxystearic acid
08/23/2012US20120214870 Methods for diagnosis and treatment of chronic fatigue syndrome
08/23/2012US20120214869 Novel ligand activators of the rar receptors and pharmaceutical/cosmetic applications thereof
08/23/2012US20120214868 Modified L-Nucleic Acid
08/23/2012US20120214865 Methods for slowing familial als disease progression
08/23/2012US20120214864 Mirnas dysregulated in triple-negative breast cancer
08/23/2012US20120214863 Anti-miR-1 Therapy for Wound Healing
08/23/2012US20120214862 Modulation of factor 7 expression
08/23/2012US20120214861 Methods and compositions for treating neurological disease
08/23/2012US20120214860 Method of regulating the expression level of survival of motor neuron 1 (smn1) and detecting enzyme activity of ubiquitin carboxyl-terminal hydrolase l1 (uchl1)
08/23/2012US20120214859 Methods and compositions for improving cognitive function
08/23/2012US20120214858 Imidamide sphingosine kinase inhibitors
08/23/2012US20120214856 Treatment for cancer
08/23/2012US20120214855 Heterocyclic compound and use thereof
08/23/2012US20120214854 Carboxy oxazole or thiazole compounds as dgat- 1 inhibitors useful for the treatment of obesity
08/23/2012US20120214853 ITE for Cancer Intervention and Eradication
08/23/2012US20120214852 Alkoxy Compounds for Disease Treatment
08/23/2012US20120214851 Aminobenzamide Derivatives as Useful Agents for Controlling Animal Parasites
08/23/2012US20120214850 Compounds for treatment of cell proliferative diseases
08/23/2012US20120214849 Dual-acting antihypertensive agents
08/23/2012US20120214848 [1,2,4]oxadiazol-3-yl acid salts and crystalline forms and their preparation
08/23/2012US20120214847 2-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
08/23/2012US20120214846 Hexahydrocyclopentyl[f]indazole pyridyl ethanols and derivatives thereof as selective glucocorticoid receptor modulators
08/23/2012US20120214845 Active metabolite of a thrombin receptor antagonist
08/23/2012US20120214843 Combination Treatment of Hydroxpyridonate Actinide/Lanthanide Decorporation Agents
08/23/2012US20120214842 Methods for treating diseases of the retina
08/23/2012US20120214841 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
08/23/2012US20120214840 Indolizine inhibitors of 5-lipoxygenase
08/23/2012US20120214839 Treatment of progressive neurodegenerative disease with ibudilast
08/23/2012US20120214838 THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS
08/23/2012US20120214837 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
08/23/2012US20120214836 Sensitizer, pharmaceutical composition, kit and use for target therapy
08/23/2012US20120214835 Sensitizer, kit and use for cancer therapy
08/23/2012US20120214834 Immune enhancement composition and kit and use thereof
08/23/2012US20120214833 Solid dispersion of rifaximin
08/23/2012US20120214832 Isoform selective phospholipase d inhibitors
08/23/2012US20120214831 Method for determination of sensitivity to anti-cancer agent
08/23/2012US20120214830 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors in hepatocellular carcinoma
08/23/2012US20120214829 Molecular Predictors of Therapeutic Response to Specific Anti-Cancer Agents
08/23/2012US20120214828 Determining sensitivity of cells to b-raf inhibitor treatment by detecting kras mutation and rtk expression levels
08/23/2012US20120214827 Anhydrous Crystalline Forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
08/23/2012US20120214826 Inhibitors of bruton's tyrosine kinase
08/23/2012US20120214825 mTOR/JAK INHIBITOR COMBINATION THERAPY
08/23/2012US20120214824 Proteostasis regulators
08/23/2012US20120214823 Novel compounds that are erk inhibitors
08/23/2012US20120214822 N-cyclopropyl-3-fluoro-5-[3-[[1-[2-[2- [(2-hydroxethyl)amino] ethoxy]phenyl] cyclopropyl] amino]-2-oxo- 1 (2h)-pyrazinyl]-4-methyl-benzamide, or pharmaceutically acceptable salts thereof and their uses
08/23/2012US20120214821 Lipidomic Biomarkers of Diabetes
08/23/2012US20120214820 Orally disintegrating pharmaceutical dosage form containing aripiprazole
08/23/2012US20120214819 Use of N--4-(3-pyridyl)-2-pyridine-amine for the Treatment of Pulmonary Hypertension
08/23/2012US20120214818 Methods of treating diastolic dysfunction and related conditions
08/23/2012US20120214817 Urotensin ii receptor antagonists
08/23/2012US20120214816 Methods and compositions for safe and effective treatment of erythema
08/23/2012US20120214815 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
08/23/2012US20120214814 Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at c-17
08/23/2012US20120214813 Isoxazole compound for the treatment of cancer
08/23/2012US20120214812 Compounds and compositions as lxr modulators
08/23/2012US20120214811 Raf inhibitor compounds and methods of use thereof
08/23/2012US20120214810 Salts of N-[6-cis-2,6-Dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
08/23/2012US20120214809 Aminoindane Compounds and Use Thereof in Treating Pain
08/23/2012US20120214808 Aryl Urea Derivatives for Treating Obesity
08/23/2012US20120214807 Compounds useful as antagonists of ccr2
08/23/2012US20120214806 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines
08/23/2012US20120214805 Bridged bicyclic piperidine derivatives and methods of use thereof
08/23/2012US20120214804 Pharmaceutical composition comprising indole compound
08/23/2012US20120214803 Novel Sulfonaminoquinoline Hepcidin Antagonists
08/23/2012US20120214802 Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof
08/23/2012US20120214801 Compositions and methods relating to novel compounds and targets thereof
08/23/2012US20120214800 Organic Compounds
08/23/2012US20120214799 Kinase inhibitors
08/23/2012US20120214798 Novel Ethanediamone Hepcidine Antagonists
08/23/2012US20120214797 Use of 5H-Dibenz/b,f/Azepine-5-Carboxamide Derivatives for Treating Fibromyalgia
08/23/2012US20120214796 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
08/23/2012US20120214795 Fused heterocyclic ring derivative and use thereof
08/23/2012US20120214794 Heteroaryls and uses thereof
08/23/2012US20120214793 Sleep aid composition and method
08/23/2012US20120214792 Thieno- adn furo-pyrimidine modulators of the histamine h4 receptor
08/23/2012US20120214791 Imidazo[5,1-f][1,2,4]Triazines for the Treatment of Neurological Disorders
08/23/2012US20120214790 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
08/23/2012US20120214789 Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists
08/23/2012US20120214788 Heteroaryl-substituted piperidines
08/23/2012US20120214787 Oxadiazole inhibitors of leukotriene production
08/23/2012US20120214786 New compounds
08/23/2012US20120214785 New compounds, pharmaceutical compositions and uses thereof
08/23/2012US20120214784 Spiropiperidine compounds as orl-1 receptor antagonists
1 ... 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 ... 7860